because the molecule is extremely cheap and can't be patented? This is from Johns Hopkins University too, not some quack on the internet: http://www.sciencedirect.com/science/article/pii/S0006291X04020625 http://www.ncbi.nlm.nih.gov/pubmed/20420565 If you can get to a university library you can see the photos of the remarkable recovery rats that were injected with cancer cells made after treatment with 3-bromopyruvate in the journal article. 19/19 rats studied were all cured and were still living after 1 year. Clinical trials in Europe are now on going and are seeing positive results. There was also rumor that a chemist in Europe somewhere got cancer, had heard of this paper, and made some crude 3-bromopyruvate in the lab out of desperation. They ended up surviving. 3-bromopyruvate has been known to have extremely interesting anti-cancer properties since 2003, so why haven't we brought it to clinical trials here in the US yet? Absolutely no pharmaceutical companies will touch it and put it into clinical trials because almost no money can be made on the molecule since it can't be patented. What should we do? Maybe this is a case where more government is good and it could step in to make this compound on an industrial scale for medical use.